JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹16 Cr | ₹16 Cr | ₹21 Cr | ₹18 Cr | ₹20 Cr |
What is the latest Total Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹18 Cr |
Mar2020 | ₹20 Cr |
How is Total Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | 3.91 | |
Mar2023 | ₹16 Cr | -25.93 | |
Mar2022 | ₹21 Cr | 18.27 | |
Mar2021 | ₹18 Cr | -9.52 | |
Mar2020 | ₹20 Cr | - |
Compare Total Current Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹423.5 Cr | -3.7% | -17.2% | 27.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -3.7% |
-17.2% |
27.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses